Phenelzine
| Phenelzine | |
|---|---|
| Salts [] | |
|---|---|
| Phenelzine sulfate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 136.19 g/mol [1] |
| Appearance | Liquid [1] |
| Melting point | 157-161ºC [1] |
| Boiling point | 74 °C at 1.00E-01 mm Hg [1] |
| Decomposition | When heated to decomposition material emits toxic fumes of /sulfur oxides and nitrogen oxides/. [1] |
| Solubility | 29.1 g/L [1] |
| Predicted LogP | 1.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C8H12N2 |
| IUPAC name | 2-phenylethylhydrazine |
| SMILES | C1=CC=C(C=C1)CCNN |
| InChI | InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2 |
| InChIKey | RMUCZJUITONUFY-UHFFFAOYSA-N |
| CAS number | 51-71-8 |
| UNII | O408N561GF |
| PubChem CID | 3675 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 11.6 hours |
| Metabolism | Liver |
| Excretion | Urine |
| Routes of administration | By mouth |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - iv: 160 mg/kg - oral: 160 mg/kg - ip: 135 mg/kg Rat: - oral: 210 mg/kg [1] |
Phenelzine (also known as Phenethylhydrazine, Fenelzyne, Hydrazine, (2-phenylethyl)-, Fenelzyna, β-Phenylethylhydrazine, (2-phenylethyl)hydrazine, Phenelzinum, Fenelzina, 1-Hydrazino-2-phenylethane or Fenelzin) is a monoamine oxidase inhibitor substance of the phenethylamine class.
Chemistry
Salts []
Stereochemistry []
Phenelzine is achiral.
Druglikeness
Lipinski's rule of five
Phenelzine matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psychoanaleptics (N06)
- antidepressants (N06A)
- monoamine oxidase inhibitors, non-selective (N06AF)
- (N06AF03)
- phenelzine (N06AF03)
MeSH Classification
Mechanism of action []
The basic mechanism of action of phenelzine acts as an inhibitor and substrate of monoamine oxidase which subsequently causes an elevation in brain levels of catecholamines and serotonin. It also presents a similar structure to amphetamine which explains the effect on the uptake and release of dopamine, noradrenaline, and serotonin. Phenelzine has been reported to inhibit tyrosine aminotransferase, aromatic amino acid decarboxylase, and dopamine B-hydroxylase. [1]
Interactions []
Medical side effects []
65 side effects listed on drug labels in SIDER 4.1 (phenelzine).
- Anxiety
- Asthenia
- Fatigue
- Ataxia
- Coma
- Constipation
- Dizziness
- Somnolence
- Oedema
- Dermatitis
- Rash
- Body temperature increased
- Glaucoma
- Headache
- Hypernatraemia
- Orthostatic hypotension
- Jaundice
- Leukopenia
- Hypertonia
- Muscle rigidity
- Nausea
- Nightmare
- Nystagmus
- Paraesthesia
- Pruritus
- Psychotic disorder
- Schizophrenia
- Convulsion
- Shock
- Sleep disorder
- Withdrawal syndrome
- Hyperhidrosis
- Tachycardia
- Tremor
- Vomiting
- Weight increased
- Dry mouth
- Urinary retention
- Agitation
- Blood creatine phosphokinase increased
- Hepatocellular injury
- Liver injury
- Mania
- Hyperreflexia
- Metabolic acidosis
- Malaise
- Discomfort
- Feeling abnormal
- Ill-defined disorder
- Muscle twitching
- Tachypnoea
- Dyspepsia
- Gastrointestinal disorder
- Anorgasmia
- Delirium
- Euphoric mood
- Erectile dysfunction
- Vision blurred
- Repetitive speech
- Hyperpyrexia
- Nervousness
- Feeling jittery
- Hypersomnia
- Insomnia
- Lupus-like syndrome
Indications
- Anxiety depression
Legal status []
- Australia: Phenelzine is a Schedule 4.
- Brazil: Phenelzine is a C1.[3]
- United States: Phenelzine is Prescription only.
- Other: Phenelzine is a Rx-only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3675, Phenelzine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3675
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Phenelzine. UNII: O408N561GF. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O408N561GF
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 10:01:03 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 10:00:59 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 10:00:59 |
| gsrs | ok | 2026-11-20 10:00:59 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014918) | 2026-11-20 10:00:59 |
| kegg | ok | 2026-11-20 10:01:01 |
| pubchem | ok | 2026-11-20 10:00:58 |
| missing (no r/tripreports posts mention it) | 2026-11-20 10:00:59 | |
| sider | ok | 2026-11-20 10:00:59 |
| structure | ok | 2026-11-20 10:00:59 |
| wikipedia | ok | 2026-11-20 10:00:59 |